HVC
ADYX

Healthcare Value Capital’s Adynxx Inc ADYX Stock Holding History

Healthcare Value Capital’s Portfolio ADYX Stock Details ADYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,017
Closed -$1.33M – 28
2015
Q3 		$1.33M Hold
7,017
– – 1.9% 15
2015
Q2 		$2.22M Buy
7,017
+3,750
+115% +$1.11M 2.33% 14
2015
Q1 		$1.02M Buy
+3,267
New +$1.06M 1.11% 19

Other funds holding ADYX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
SCM
Suffolk Capital Management New York $521M AUM 9.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Healthcare Value Capital's ADYX Position: Q4 2015 in Review

Healthcare Value Capital sold out of Adynxx Inc (ADYX) in Q4 2015, closing a stake of 7,017 shares — an estimated $1.33M sold.

Healthcare Value Capital first reported a position in ADYX in Q1 2015 and held it in 3 quarters. The position peaked at $2.22M in Q2 2015. 46 funds tracked by Wall St. Rank hold ADYX as of Q4 2015.

  • Healthcare Value Capital reported no remaining Adynxx Inc position as of Q4 2015 after selling out during the quarter.
  • Healthcare Value Capital sold 7,017 Adynxx Inc shares in Q4 2015, an estimated $1.33M.
  • Healthcare Value Capital first reported a position in Adynxx Inc in Q1 2015 and held it in 3 quarters.
  • Healthcare Value Capital's Adynxx Inc position peaked at $2.22M in Q2 2015.
  • 46 funds tracked by Wall St. Rank held Adynxx Inc as of Q4 2015.

Based on Healthcare Value Capital's 13F filing for Q4 2015, filed 16 Feb 2016.